Monday, July 7, 2025
19 C
London

Tag: Drug Controller General of India

For children aged 2 to 18, India’s expert group on COVID-19 recommends Bharat Biotech’s Covaxin

The COVID-19 Subject Expert Committee of the Indian government has endorsed Bharat Biotech's Covaxin for children aged 2 to 18.

NTAGI recommends a 12-16 week gap between two doses of COVISHIELD

Govt Panel recommends 12-16 week gap between COVISHIELD doses, no change for COVAXIN The National Technical Advisory Group on Immunisation...